Moderna Reports RSV Vaccine Cuts Risk of Respiratory Diseases in Older Adults - The Wall Street Journal
- Moderna Reports RSV Vaccine Cuts Risk of Respiratory Diseases in Older Adults The Wall Street Journal
- Moderna says RSV vaccine is 84% effective at preventing disease in older adults CNBC
- Moderna's phase three RSV trial found to be 83.7% effective in older adults CNBC Television
- Moderna says RSV vaccine 84% effective at preventing symptoms in older adults Yahoo News
- Why Moderna Stock Is Surging After Hours Benzinga
- View Full Coverage on Google News